Work by UB mathematician Gino Biondini builds on centuries of research devoted to using math to describe the physical world.

Zachary del Rosario has received funding from the National Science Foundation and Toyota Research Institute. Probability underpins AI, cryptography and statistics. However, as the philosopher Bertrand ...

Applied Behavior Analysis (ABA) looks different for every child, with a unique set of goals. (Photo Credit: E+/Getty Images) ABA is a type of interpersonal therapy. Your child usually works with a ...

CAMBRIDGE, England & DETROIT--(BUSINESS WIRE)--Cycle Group Holdings Limited (“Cycle”) is delighted to announce it has completed the acquisition of NASDAQ-listed Applied Therapeutics, Inc. (NASDAQ: ...

If someone told you that they were “probably” going to have pasta for dinner, but you later found out that they ate pizza, would you feel surprised – or even lied to? More seriously, what does it mean ...

STEM-OPT Visa Eligible: The STEM Optional Practical Training (OPT) program allows full-time, on-campus international students on an F-1 student visa to stay and work in the U.S. for up to three years ...

Applied Behavior Analysis (ABA) is a type of therapy frequently applied to children with autism and other developmental disorders that focuses on imparting skills in specific domains of functioning, ...

The data center developer enjoys an unusually high level of demand visibility. Applied Digital is transitioning from construction to recurring revenue generation. Management expects to reach $1 ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

Applied Digital boasts an exceptionally strong long-term demand visibility. The company is focused on rapidly expanding its data center capacity to meet surging demand. Applied Digital has also ...

Cycle Pharmaceuticals is circling up Applied Therapeutics, acquiring the rare disease biotech after an extremely tumultuous year for the latter that began with an FDA rejection at the end of 2024.